A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
Clinical trial NCT05757102 · RECRUITING
Trial details
- NCT number
- NCT05757102
- Sponsor
- GlaxoSmithKline
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-25
- Primary completion
- 2027-01-22
- Enrollment
- 292
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.